Cargando…
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study
AIM: To show equivalent bosentan exposure in paediatric patients with pulmonary arterial hypertension (PAH) when compared with a cohort of historical controls of adult PAH patients using a newly developed paediatric formulation. METHODS: Thirty-six paediatric PAH patients were enrolled in this multi...
Autores principales: | Beghetti, Maurice, Haworth, Sheila G, Bonnet, Damien, Barst, Robyn J, Acar, Philippe, Fraisse, Alain, Ivy, Dunbar D, Jais, Xavier, Schulze-Neick, Ingram, Galiè, Nazzareno, Morganti, Adele, Dingemanse, Jasper, Kusic-Pajic, Andjela, Berger, Rolf M F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805863/ https://www.ncbi.nlm.nih.gov/pubmed/20002090 http://dx.doi.org/10.1111/j.1365-2125.2009.03532.x |
Ejemplares similares
-
A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE‐3
por: Berger, Rolf M. F., et al.
Publicado: (2017) -
Echocardiographic Changes and Long-Term Clinical Outcomes in Pediatric Patients With Pulmonary Arterial Hypertension Treated With Bosentan for 72 Weeks: A Post-hoc Analysis From the FUTURE 3 Study
por: Beghetti, Maurice, et al.
Publicado: (2021) -
Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension
por: Barst, Robyn J., et al.
Publicado: (2012) -
Health outcomes, healthcare use and development in children born into or growing up in single-parent households: a systematic review study protocol
por: Lut, Irina, et al.
Publicado: (2021) -
Bosentan monohydrate
por: Kaur, Manpreet, et al.
Publicado: (2012)